Rising Adoption Of Regenerative Medicine Is Driving The Cell Therapy Human Raw Materials Market: Major Factor in the Transformation of the Cell Therapy Human Raw Materials Market in 2025

How Will the Cell Therapy Human Raw Materials Market Grow, and What Is the Projected Market Size?
The market size for human raw materials in cell therapy has witnessed a rapid expansion in the past few years. The expected growth is projected from $2.82 billion in 2024 to $3.39 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 20.4%. Factors contributing to growth during the historical period include the rising occurrence of chronic illnesses, growing elderly population, surging demand for regenerative medical treatments, governmental financial backing and encouragement, and a rise in healthcare spending.

The market size for human raw materials in cell therapy is anticipated to undergo significant expansion in the following years. It is projected to peak at $7.05 billion by 2029, with a compound annual growth rate (CAGR) of 20.1%. The predicted growth in the coming period is tied to the increasing therapeutic usage, heightened patient knowledge, positive regulatory structures, an expanding biopharmaceutical industry, and enhancements in production methods. Key trends for the forthcoming period incorporate the adoption of allogeneic therapies, the incorporation of artificial intelligence, the growth in off-the-shelf cell therapies, the application of 3D bioprinting technology, and the progression of hybrid cell therapies.

What Key Elements Are Boosting Growth in the Cell Therapy Human Raw Materials Market?
The cell therapy human raw materials market is anticipated to flourish due to the increasing uptake of regenerative medicine. Regenerative medicine applies the body's natural regenerative abilities or external factors like stem cells, tissue engineering, or gene therapy, aiming for the restoration, repair, or regeneration of impaired tissues and organs to achieve normal functioning. It's gaining prominence with advancements in biotechnology, an enhanced understanding of cellular mechanisms, a surge in the requirement for personalized medicine, and the ability to cater to unaddressed medical needs more effectively. Cell therapy and human raw materials support the uptake of regenerative medicine by supplying the necessary biological elements for cell-based therapies, thereby facilitating the creation of standardized and dependable treatments for various health issues. As an example, a report by the Alliance for Regenerative Medicine, a US non-profit organization, stated in August 2023 that there were 2760 cell, gene, and tissue-engineering therapeutic developers globally in Q1 2023, marking a 101% increase from 1369 in Q1 2022. As such, the escalating adoption of regenerative medicine propels the cell therapy human raw materials market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp

Who Are the Major Industry Players Fueling Cell Therapy Human Raw Materials Market Expansion?
Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.

Which Key Developments Are Influencing the Cell Therapy Human Raw Materials Market?
The emphasis on developing chemically defined cell culture mediums by leading companies in the cell therapy human raw materials market is becoming increasingly pronounced, as a push for accelerating the development of cell therapy. Designed to nourish, a cell culture medium serves as an optimal solution providing essential nutrients, growth factors, and maintaining the necessary environmental conditions to ensure cell growth and propagation outside of their natural surroundings. A case in point is the TheraPEAK T-VIVO Cell Culture Medium, launched by the Switzerland-based healthcare manufacturing company, Lonza Group AG, in May 2023. This newly introduced medium stands out for its chemically defined formulation, being serum and animal component-free, incorporation of recombinant proteins, and offering enhanced culture and expansion support along with application aid. These factors together ensure sustained consistency, safety, and regulatory compliance in cell therapy manufacturing. Removal of animal components from this medium, use of chemically defined formulation, and regulatory-friendly attributes mark significant advancements in technology, adding to the improvement in safety, quality, and regulatory compliance.

How Is the Segmentation of the Cell Therapy Human Raw Materials Market Defined?
The cell therapy human raw materials market covered in this report is segmented -

1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions

Subsegments:
1) By Cell Culture Media: Serum-Free Media, Serum-Based Media, Defined Media, Specialized Media (E.G., For Stem Cells)
2) By Cell Culture Sera: Fetal Bovine Serum (FBS), Human Serum, Adult Bovine Serum
3) By Cell Culture Supplements: Growth Factors, Cytokines, Peptides
4) By Reagents And Buffers: Enzymes (E.G., Trypsin), Ph Buffers, Cryoprotectants
5) By Other Raw Materials: Cell-Free DNA, Plasma And Platelet-Rich Plasma (PRP), Vials And Storage Containers

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

What Is the Leading Region in the Cell Therapy Human Raw Materials Market?
North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Cell Therapy Human Raw Materials Global Market Report?

- Market Size Analysis: Analyze the Cell Therapy Human Raw Materials Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Cell Therapy Human Raw Materials Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Cell Therapy Human Raw Materials Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Cell Therapy Human Raw Materials Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15759

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.